Helix Acquisition Corp. II Class A Ordinary Shares (HLXB) 10-Q 14 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 14, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	HELIX ACQUISITION CORP. II
Entity Central Index Key	0001869105
Entity File Number	001-41955
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	E9
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	200 Clarendon Street
Entity Address, Address Line Two	52nd Floor
Entity Address, City or Town	Boston
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02116
Entity Phone Fax Numbers [Line Items]
City Area Code	(857)
Local Phone Number	702-0370
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary share, par value $0.0001 per share
Trading Symbol	HLXB
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		18,909,000
Class B Ordinary Shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		4,600,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)		Sep. 30, 2024		Dec. 31, 2023
Current assets
Cash		$ 1,785,636
Prepaid expense		6,327
Prepaid insurance – current portion		249,840
Total current assets		2,041,803
Deferred offering costs				332,894
Long-term prepaid insurance		87,588
Marketable securities held in Trust Account		190,203,404
TOTAL ASSETS		192,332,795		332,894
Current liabilities
Accrued offering costs				311,368
Accrued expenses		126,690		15,000
Promissory note – related party				70,095
Total current liabilities		126,690		396,463
Deferred underwriting fee		5,520,000
TOTAL LIABILITIES		5,646,690		396,463
Commitments (Note 6)
SHAREHOLDERS’ DEFICIT
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2024 and December 31, 2023
Additional paid-in capital				24,540
Accumulated deficit		(3,517,810)		(88,569)
TOTAL SHAREHOLDERS’ DEFICIT		(3,517,299)	[1]	(63,569)	[2]
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT		192,332,795		332,894
Class A Ordinary Shares
Current liabilities
Class A ordinary shares subject to possible redemption, 18,400,000 shares at redemption value of $10.34 per share as of September 30, 2024 and 0 shares at December 31, 2023		190,203,404
SHAREHOLDERS’ DEFICIT
Ordinary shares, value		51
Class B Ordinary Shares
SHAREHOLDERS’ DEFICIT
Ordinary shares, value	[3]	$ 460		$ 460
[1] On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. Includes an aggregate of up to 600,000 Class B ordinary shares that are subject to forfeiture depending on the extent to which the underwriter’s over-allotment option is exercised. On February 13, 2024, simultaneously with the closing of the Initial Public Offering, the underwriter fully exercised its over-allotment option, and accordingly, the 600,000 Founder Shares are no longer subject to forfeiture (Note 5). On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor.

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares		Sep. 30, 2024	Dec. 31, 2023
Preference shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Preference shares, shares authorized		5,000,000	5,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Ordinary shares subject to possible redemption		18,400,000	18,400,000
Ordinary shares subject to possible redemption per share (in Dollars per share)		$ 10.34	$ 0
Ordinary shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Ordinary shares, shares authorized		500,000,000	500,000,000
Ordinary shares, shares issued		509,000	0
Ordinary shares, shares outstanding		509,000	0
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	[1]	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	[1]	50,000,000	50,000,000
Ordinary shares, shares issued	[1]	4,600,000	4,600,000
Ordinary shares, shares outstanding	[1]	4,600,000	4,600,000
[1] On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor.

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
General and administrative expenses		$ 146,852		$ 365,896
Loss from operations		(146,852)		(365,896)
Other income (expense):
Share-based compensation expense		(77,400)		(194,172)
Interest earned on bank deposits		3,000		3,000
Interest earned on marketable securities held in Trust Account		2,554,610		6,203,404
Total other income (expense)		2,480,210		6,012,232
Net income		$ 2,333,358		$ 5,646,336
Class A Ordinary Shares
Other income (expense):
Basic weighted average shares outstanding (in Shares)	[1]	18,909,000		15,872,518
Basic net income per share (in Dollars per share)		$ 0.1		$ 0.28
Diluted weighted average shares outstanding (in Shares)	[1]	18,909,000		15,872,518
Diluted net income per share (in Dollars per share)		$ 0.1		$ 0.28
Class B Ordinary Shares
Other income (expense):
Basic weighted average shares outstanding (in Shares)	[1],[2],[3]	4,600,000	4,000,000	4,503,650	4,000,000
Basic net income per share (in Dollars per share)		$ 0.1	$ 0	$ 0.28	$ 0
Diluted weighted average shares outstanding (in Shares)	[1],[2],[3]	4,600,000	4,000,000	4,600,000	4,000,000
Diluted net income per share (in Dollars per share)		$ 0.1	$ 0	$ 0.28	$ 0
[1] At September 30, 2023, excludes an aggregate of 600,000 Class B ordinary shares that are subject to forfeiture. As of September 30, 2023, excludes an aggregate of up to 600,000 Class B ordinary shares that are subject to forfeiture depending on the extent to which the underwriter’s over-allotment option is exercised. On February 13, 2024, simultaneously with the closing of the Initial Public Offering, the underwriter fully exercised its over-allotment option, and accordingly, the 600,000 Founder Shares are no longer subject to forfeiture (Note 5). On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor.

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)		Ordinary Shares Class A	Ordinary Shares Class B	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022			$ 460	$ 24,540	$ (46,877)	$ (21,877)
Balance (in Shares) at Dec. 31, 2022			4,600,000
Net income (loss)
Balance at Mar. 31, 2023	[1]		$ 460	24,540	(46,877)	(21,877)
Balance (in Shares) at Mar. 31, 2023	[1]		4,600,000
Balance at Dec. 31, 2022			$ 460	24,540	(46,877)	(21,877)
Balance (in Shares) at Dec. 31, 2022			4,600,000
Net income (loss)
Balance at Sep. 30, 2023	[1]		$ 460	24,540	(46,877)	(21,877)
Balance (in Shares) at Sep. 30, 2023	[1]		4,600,000
Balance at Mar. 31, 2023	[1]		$ 460	24,540	(46,877)	(21,877)
Balance (in Shares) at Mar. 31, 2023	[1]		4,600,000
Net income (loss)
Balance at Jun. 30, 2023	[1]		$ 460	24,540	(46,877)	(21,877)
Balance (in Shares) at Jun. 30, 2023	[1]		4,600,000
Net income (loss)
Balance at Sep. 30, 2023	[1]		$ 460	24,540	(46,877)	(21,877)
Balance (in Shares) at Sep. 30, 2023	[1]		4,600,000
Balance at Dec. 31, 2023	[1]		$ 460	24,540	(88,569)	(63,569)
Balance (in Shares) at Dec. 31, 2023	[1]		4,600,000
Sale of 509,000 Private Placement Shares		$ 51		5,089,949		5,090,000
Sale of 509,000 Private Placement Shares (in Shares)		509,000
Allocated value of transaction costs to private shares				(22,096)		(22,096)
Share-based compensation expense				39,372		39,372
Accretion of Class A ordinary shares subject to possible redemption				(5,131,765)	(4,233,488)	(9,365,253)
Net income (loss)					1,100,442	1,100,442
Balance at Mar. 31, 2024	[2]	$ 51	$ 460		(3,221,615)	(3,221,104)
Balance (in Shares) at Mar. 31, 2024	[2]	509,000	4,600,000
Balance at Dec. 31, 2023	[1]		$ 460	24,540	(88,569)	(63,569)
Balance (in Shares) at Dec. 31, 2023	[1]		4,600,000
Net income (loss)						5,646,336
Balance at Sep. 30, 2024	[2]	$ 51	$ 460		(3,517,810)	(3,517,299)
Balance (in Shares) at Sep. 30, 2024	[2]	509,000	4,600,000
Balance at Mar. 31, 2024	[2]	$ 51	$ 460		(3,221,615)	(3,221,104)
Balance (in Shares) at Mar. 31, 2024	[2]	509,000	4,600,000
Share-based compensation expense				77,400		77,400
Accretion of Class A ordinary shares subject to possible redemption				(77,400)	(2,364,879)	(2,442,279)
Net income (loss)					2,212,536	2,212,536
Balance at Jun. 30, 2024	[2]	$ 51	$ 460		(3,373,958)	(3,373,447)
Balance (in Shares) at Jun. 30, 2024	[2]	509,000	4,600,000
Share-based compensation expense				77,400		77,400
Accretion of Class A ordinary shares subject to possible redemption				(77,400)	(2,477,210)	(2,554,610)
Net income (loss)					2,333,358	2,333,358
Balance at Sep. 30, 2024	[2]	$ 51	$ 460		$ (3,517,810)	$ (3,517,299)
Balance (in Shares) at Sep. 30, 2024	[2]	509,000	4,600,000
[1] Includes an aggregate of up to 600,000 Class B ordinary shares that are subject to forfeiture depending on the extent to which the underwriter’s over-allotment option is exercised. On February 13, 2024, simultaneously with the closing of the Initial Public Offering, the underwriter fully exercised its over-allotment option, and accordingly, the 600,000 Founder Shares are no longer subject to forfeiture (Note 5). On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor.

Condensed Statements of Chang_2

Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) (Parentheticals)	3 Months Ended
	Mar. 31, 2024 shares
Ordinary Shares | Class A
Sale of Private Placement Shares	509,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities:
Net income	$ 5,646,336
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(6,203,404)
Non-cash accrued offering costs adjustment	(81,000)
Share-based compensation expense	194,172
Changes in operating assets and liabilities:
Prepaid expense	(6,327)
Short-term prepaid insurance	(249,840)
Long-term prepaid insurance	(87,588)
Accrued expenses	111,690
Net cash used in operating activities	(675,961)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(184,000,000)
Net cash used in investing activities	(184,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Private Placement Shares, net of underwriting discounts paid	182,160,000
Proceeds from sale of Private Placement Shares	5,090,000
Repayment of promissory note – related party	(209,853)
Payment of offering costs	(578,550)
Net cash provided by financing activities	186,461,597
Net Change in Cash	1,785,636
Cash – Beginning of period
Cash – End of period	1,785,636
Non-cash investing and financing activities:
Deferred offering costs paid by Sponsor through promissory note	$ 139,758

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2024
Description of Organization and Business Operations [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Helix Acquisition Corp. II (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 15, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination but intends to focus on healthcare and healthcare related industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2024, the Company had not commenced any operations. All activity for the period from June 15, 2021 (inception) through September 30, 2024 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on February 8, 2024. On February 13, 2024, the Company consummated the Initial Public Offering of 18,400,000 Class A ordinary shares (the “Public Shares”), which includes the full exercise by the underwriter of its over-allotment option in the amount of 2,400,000 Public Shares, at $10.00 per Public Share, generating gross proceeds of $184,000,000, which is discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 509,000 Class A ordinary shares (the “Private Placement Shares”) to Helix Holdings II, LLC (the “Sponsor”) at a price of $10.00 per Private Placement Share, or $5,090,000 in the aggregate, which is described in Note 4. Transaction costs amounted to $8,180,834, consisting of $1,840,000 of upfront cash underwriting fee, $5,520,000 of deferred underwriting fee (see additional discussion on Note 6), and $820,834 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of Nasdaq require that the Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. The Company anticipates structuring the initial Business Combination so that the post transaction company in which the Public Shareholders (as defined below) own shares will own or acquire 100% of the equity interests or assets of the target business or businesses. The Company may, however, structure the initial Business Combination such that the post transaction company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but the Company will only complete such Business Combination if the post transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Following the closing of the Initial Public Offering, on February 13, 2024, an amount of $184,000,000 ($10.00 per Share) from the net proceeds of the sale of the Public Shares and the sale of the Private Placement Shares, after deducting $1,840,000 in underwriting discounts and commissions paid upon the closing of the Initial Public Offering and an aggregate of $3,250,000 to pay fees and expenses in connection with the closing of the Initial Public Offering and for working capital following the closing, was placed in the trust account (“Trust Account”), and either held in cash, deposited into an interest bearing or non-interest bearing bank demand deposit account at a U.S. chartered commercial bank with consolidated assets of $100 billion or more, or invested in U.S. government securities within the meaning of Section 2(a)(16) of the Investment company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earliest of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company will provide the holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated to be $10.00 per Public Share), including interest (less taxes paid or payable), divided by the number of then issued and outstanding Public Shares, subject to certain limitations as described in the prospectus. The per-share amount to be distributed to the Public Shareholders who properly redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). The Class A ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares (as defined below), Private Placement Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Completion Window (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust Account (less taxes paid or payable), divided by the number of then issued and outstanding Public Shares. The Company will have until (i) the period ending on the date that is 24 months from the closing of the Initial Public Offering, or such earlier liquidation as the Company’s board of directors may approve, in which the Company must complete an initial Business Combination or (ii) such other time period in which the Company must complete an initial Business Combination pursuant to an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (the “Completion Window”). However, if the Company has not completed a Business Combination within the Completion Window, the Company will as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes paid or payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will constitute full and complete payment for the Public Shares and completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law. The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Placement Shares if the Company fails to complete a Business Combination within the Completion Window. However, the Public Shares acquired by affiliates of the Sponsor in the Initial Public Offering, and any other Public Shares that the Sponsor or its affiliates may acquire thereafter, will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Completion Window. The underwriter has agreed to waive its rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Completion Window, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Share ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, less taxes paid or payable and up to $100,000 of interest to pay dissolution expenses, provided that this liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus for its Initial Public Offering as filed with the SEC on February 13, 2024, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on February 20, 2024. The interim results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of other income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $1,785,636 and $0 in cash as of September 30, 2024 and December 31, 2023, respectively, and no cash equivalents as of such dates. Marketable Securities Held in Trust Account At September 30, 2024, substantially all of the assets held in the Trust Account were held in U.S. Treasury bills. The Company accounts for its marketable securities as trading securities under ASC 320, “Investments—Debt and Equity Securities”, where securities are presented at fair value on the condensed balance sheets. Gains and losses resulting from the change in fair value of marketable securities held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the condensed statements of operations. As of September 30, 2024, the Company has not withdrawn any interest earned on the Trust Account. As of December 31, 2023, there were no funds deposited in the Trust Account. Offering Costs The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. Financial Accounting Standards Board (“FASB”) ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. Offering costs allocated to the Public Shares were charged to temporary equity. Class A Redeemable Share Classification The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes change in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, at September 30, 2024, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. At September 30, 2024, the Class A ordinary shares subject to redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 184,000,000 Less: Class A ordinary shares issuance costs (8,158,738 ) Plus: Accretion of carrying value to redemption value 14,362,142 Class A ordinary shares subject to possible redemption, September 30, 2024 $ 190,203,404 Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2024 and December 31, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was $0 for the periods presented. Net Income per Ordinary Share Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. The Company complies with accounting and disclosure requirements of the FASB ASC Topic 260, “Earnings Per Share.” Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Basic and diluted net income per ordinary share for Class A ordinary shares and Class B ordinary shares is calculated by dividing net income attributable to the Company by the weighted average number of Class A ordinary shares and Class B ordinary shares outstanding, allocated proportionally to each class of ordinary shares. This presentation assumes a Business Combination as the most likely outcome. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following tables reflect the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Basic net income per share Numerator: Allocation of net income $ 1,876,790 $ 456,568 $ — $ — $ 4,398,352 $ 1,247,984 $ — $ — Denominator: Basic weighted average shares outstanding (1) 18,909,000 4,600,000 — 4,000,000 15,872,518 4,503,650 — 4,000,000 Basic net income per share $ 0.10 $ 0.10 $ — $ 0.00 $ 0.28 $ 0.28 $ — $ 0.00 For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Diluted net income per share Numerator: Allocation of net income $ 1,876,790 $ 456,568 $ — $ — $ 4,377,652 $ 1,268,684 $ — $ — Denominator: Diluted weighted average shares outstanding (1) 18,909,000 4,600,000 — 4,000,000 15,872,518 4,600,000 — 4,000,000 Diluted net income per share $ 0.10 $ 0.10 $ — $ 0.00 $ 0.28 $ 0.28 $ — $ 0.00 (1) At September 30, 2023, excludes an aggregate of 600,000 Class B ordinary shares that are subject to forfeiture. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. Share-Based Compensation The Company records share-based compensation in accordance with FASB ASC Topic 718, “Compensation-Share Compensation” (“ASC 718”), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the condensed statements of operations. Recent Accounting Standards In March 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-01, “Compensation - Stock Compensation (Topic 718): Scope Application of Profit Interest and Similar Awards” (“ASU 2024-01”). This ASU provides clarification on when profit interest awards should be accounted for similar to a cash bonus or profit-sharing arrangement in accordance with ASC 710 or as a share-based payment arrangement in accordance with ASC 718. The FASB issued this ASU to address diversity in the practice of accounting for profit interest awards. Management does not believe the adoption of ASU 2024-01 will have a material impact on the accompanying unaudited condensed financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Public Offering

Public Offering	9 Months Ended
	Sep. 30, 2024
Public Offering [Abstract]
PUBLIC OFFERING	NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 18,400,000 Public Shares, which includes a full exercise by the underwriter of their over-allotment option in the amount of 2,400,000 Public Shares, at a price of $10.00 per Public Share.

Private Placement

Private Placement	9 Months Ended
	Sep. 30, 2024
Private Placements [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 509,000 Private Placement Shares at a price of $10.00 per Private Placement Share, for an aggregate purchase price of $5,090,000. A portion of the proceeds from the Private Placement Shares was added to the proceeds from the Initial Public Offering and are held in the Trust Account.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On June 19, 2021, Sponsor paid $25,000 to cover certain offering and formation costs of the Company in exchange for 2,875,000 Class B ordinary shares (the “Founder Shares”). The Founder Shares included an aggregate of up to 562,500 shares that were subject to forfeiture depending on the extent to which the underwriter’s over-allotment option was exercised, so that the number of Founder Shares would equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering (excluding any Public Shares purchased by the Sponsor in the Initial Public Offering and excluding the Private Placement Shares). On November 29, 2023, the Sponsor assigned 30,000 Founder Shares to each of the Company’s independent directors, Mark McKenna and John Schmid, and to the Company’s advisor, Andrew Phillips. On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 shares, resulting in the Sponsor holding a total of 4,222,500 Founder Shares. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 shares, resulting in the Sponsor holding a total of 4,510,000 Founder Shares and the Company’s two independent directors and one advisor (together with the Sponsor, the “Insiders”) each holding 30,000 Founder Shares, which were retroactively presented on the financial statements, with up to 600,000 Founder Shares held by the Sponsor subject to forfeiture depending on the extent to which the underwriter’s over-allotment option was exercised. On February 11, 2024, the underwriter of the Initial Public Offering delivered the Company a notice of its intention to fully exercise the over-allotment option and on February 13, 2024, simultaneously with the closing of the Initial Public Offering, the underwriter purchased the additional 2,400,000 Public Shares at a price of $10.00 per Public Share. Accordingly, the Founder Shares are no longer subject to forfeiture. The Insiders have each agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. The sale or allocation of the Founder Shares to the Company’s director nominees, as described above, is within the scope ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 90,000 Founder Shares transferred to the Company’s independent directors and advisor on November 29, 2023 is $309,600 or $3.44 per share. The Founder Shares were granted subject to a service condition (i.e., being part of the Company at the date of the Initial Public Offering through one year from the Initial Public Offering). Stock-based compensation will be recognized ratably from the date of the Initial Public Offering through the one-year anniversary of the Initial Public Offering in an amount equal to the number of Founder Shares times the grant date fair value per share less the amount initially received for the purchase of the Founder Shares. Administrative Services and Indemnification Agreement The Company entered into an agreement, commencing on February 8, 2024, through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of $6,458 per month for office space, utilities and secretarial, and administrative support services. In addition, the Company has agreed that it will indemnify the Sponsor, members and managers and representatives of the Sponsor (collectively, “Sponsor Indemnitees”) from any claims arising out of or relating to the Initial Public Offering or the Company’s operations or conduct of the Company’s business or any claim against any Sponsor Indemnitees alleging any expressed or implied management or endorsement by Sponsor Indemnitees of any of the Company’s activities or any express or implied association between Sponsor Indemnitees, on the one hand, and the Company or any of its other affiliates, on the other hand. For the three and nine months ended September 30, 2024, the Company incurred $19,374 and $48,435 in fees for these services, respectively, of which such amounts are included in accrued expenses in the accompanying condensed balance sheets. For the three and nine months ended September 30, 2023, the Company did not incur any such fees for these services. Promissory Note — Related Party On June 19, 2021, as amended in October 2023, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2024 or (ii) the completion of the Initial Public Offering. As of September 30, 2024 and December 31, 2023, the Company had $0 and $70,095 outstanding under the Promissory Note, respectively. Borrowing under the note is no longer available. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into private placement shares of the post-Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of September 30, 2024 and December 31, 2023, the Company had no outstanding borrowings under the Working Capital Loans.

Commitments

Commitments	9 Months Ended
	Sep. 30, 2024
Commitments [Abstract]
COMMITMENTS	NOTE 6. COMMITMENTS Registration Rights The holders of the Founder Shares, Private Placement Shares and any shares that may be issued upon conversion of Working Capital Loans have registration rights pursuant to a registration rights agreement dated as of February 8, 2024 (the “Registration Rights Agreement”). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the Registration Rights Agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Registration Rights Agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriter a 45-day option to purchase up to 2,400,000 additional Public Shares to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On February 11, 2024, the underwriter delivered the Company a notice of its intention to fully exercise the over-allotment option and on February 13, 2024, simultaneously with the closing of the Initial Public Offering, the underwriter purchased the additional 2,400,000 Public Shares at a price of $10.00 per Public Share. The underwriter was entitled to an upfront cash underwriting discount of $0.10 per Public Share, or $1,840,000 in the aggregate, paid upon the closing of the Initial Public Offering. In addition, the underwriter is entitled to a deferred fee of $0.30 per Public Share, or $5,520,000 in the aggregate. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Shareholders_ Deficit

Shareholders’ Deficit	9 Months Ended
	Sep. 30, 2024
Shareholders’ Deficit [Abstract]
SHAREHOLDERS’ DEFICIT	NOTE 7. SHAREHOLDERS’ DEFICIT Preference Shares no Class A Ordinary Shares Class B Ordinary Shares Holders of record of Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except to vote to approve any transfer by way of continuation pursuant to the Company’s Amended and Restated Memorandum and Articles of Association or as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination (including the forward purchase shares, but not the forward purchase agreements), excluding any forward purchases securities and Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in a Business Combination and any Private Placement Shares issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 8. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability. At September 30, 2024, assets held in the Trust Account were comprised of $919 in cash and $190,202,485 in U.S. Treasury Bills. As of September 30, 2024, the Company did not withdraw any interest income from the Trust Account. At December 31, 2023, there were no assets held in the Trust Account. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: September 30, December 31, Description Level 2024 2023 Assets: U.S. Treasury Bills held in Trust Account (Matures on November 14, 2024) 1 $ 190,202,485 $ —

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 2,333,358	$ 2,212,536	$ 1,100,442				$ 5,646,336

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus for its Initial Public Offering as filed with the SEC on February 13, 2024, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on February 20, 2024. The interim results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of other income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash	Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $1,785,636 and $0 in cash as of September 30, 2024 and December 31, 2023, respectively, and no cash equivalents as of such dates.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At September 30, 2024, substantially all of the assets held in the Trust Account were held in U.S. Treasury bills. The Company accounts for its marketable securities as trading securities under ASC 320, “Investments—Debt and Equity Securities”, where securities are presented at fair value on the condensed balance sheets. Gains and losses resulting from the change in fair value of marketable securities held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the condensed statements of operations. As of September 30, 2024, the Company has not withdrawn any interest earned on the Trust Account. As of December 31, 2023, there were no funds deposited in the Trust Account.
Offering Costs	Offering Costs The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. Financial Accounting Standards Board (“FASB”) ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. Offering costs allocated to the Public Shares were charged to temporary equity.
Class A Redeemable Share Classification	Class A Redeemable Share Classification The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes change in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, at September 30, 2024, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. At September 30, 2024, the Class A ordinary shares subject to redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 184,000,000 Less: Class A ordinary shares issuance costs (8,158,738 ) Plus: Accretion of carrying value to redemption value 14,362,142 Class A ordinary shares subject to possible redemption, September 30, 2024 $ 190,203,404
Income Taxes	Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2024 and December 31, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was $0 for the periods presented.
Net Income per Ordinary Share	Net Income per Ordinary Share Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. The Company complies with accounting and disclosure requirements of the FASB ASC Topic 260, “Earnings Per Share.” Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Basic and diluted net income per ordinary share for Class A ordinary shares and Class B ordinary shares is calculated by dividing net income attributable to the Company by the weighted average number of Class A ordinary shares and Class B ordinary shares outstanding, allocated proportionally to each class of ordinary shares. This presentation assumes a Business Combination as the most likely outcome. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following tables reflect the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Basic net income per share Numerator: Allocation of net income $ 1,876,790 $ 456,568 $ — $ — $ 4,398,352 $ 1,247,984 $ — $ — Denominator: Basic weighted average shares outstanding (1) 18,909,000 4,600,000 — 4,000,000 15,872,518 4,503,650 — 4,000,000 Basic net income per share $ 0.10 $ 0.10 $ — $ 0.00 $ 0.28 $ 0.28 $ — $ 0.00 For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Diluted net income per share Numerator: Allocation of net income $ 1,876,790 $ 456,568 $ — $ — $ 4,377,652 $ 1,268,684 $ — $ — Denominator: Diluted weighted average shares outstanding (1) 18,909,000 4,600,000 — 4,000,000 15,872,518 4,600,000 — 4,000,000 Diluted net income per share $ 0.10 $ 0.10 $ — $ 0.00 $ 0.28 $ 0.28 $ — $ 0.00 (1) At September 30, 2023, excludes an aggregate of 600,000 Class B ordinary shares that are subject to forfeiture.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.
Share-Based Compensation	Share-Based Compensation The Company records share-based compensation in accordance with FASB ASC Topic 718, “Compensation-Share Compensation” (“ASC 718”), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the condensed statements of operations.
Recent Accounting Standards	Recent Accounting Standards In March 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-01, “Compensation - Stock Compensation (Topic 718): Scope Application of Profit Interest and Similar Awards” (“ASU 2024-01”). This ASU provides clarification on when profit interest awards should be accounted for similar to a cash bonus or profit-sharing arrangement in accordance with ASC 710 or as a share-based payment arrangement in accordance with ASC 718. The FASB issued this ASU to address diversity in the practice of accounting for profit interest awards. Management does not believe the adoption of ASU 2024-01 will have a material impact on the accompanying unaudited condensed financial statements and disclosures. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Schedule of Class A Ordinary Shares Subject to Redemption Reflected	At September 30, 2024, the Class A ordinary shares subject to redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 184,000,000 Less: Class A ordinary shares issuance costs (8,158,738 ) Plus: Accretion of carrying value to redemption value 14,362,142 Class A ordinary shares subject to possible redemption, September 30, 2024 $ 190,203,404
Schedule of Basic and Diluted Net Income Per Ordinary Share	The following tables reflect the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Basic net income per share Numerator: Allocation of net income $ 1,876,790 $ 456,568 $ — $ — $ 4,398,352 $ 1,247,984 $ — $ — Denominator: Basic weighted average shares outstanding (1) 18,909,000 4,600,000 — 4,000,000 15,872,518 4,503,650 — 4,000,000 Basic net income per share $ 0.10 $ 0.10 $ — $ 0.00 $ 0.28 $ 0.28 $ — $ 0.00 For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Diluted net income per share Numerator: Allocation of net income $ 1,876,790 $ 456,568 $ — $ — $ 4,377,652 $ 1,268,684 $ — $ — Denominator: Diluted weighted average shares outstanding (1) 18,909,000 4,600,000 — 4,000,000 15,872,518 4,600,000 — 4,000,000 Diluted net income per share $ 0.10 $ 0.10 $ — $ 0.00 $ 0.28 $ 0.28 $ — $ 0.00 (1) At September 30, 2023, excludes an aggregate of 600,000 Class B ordinary shares that are subject to forfeiture.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Measurements [Abstract]
Schedule of Assets that are Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: September 30, December 31, Description Level 2024 2023 Assets: U.S. Treasury Bills held in Trust Account (Matures on November 14, 2024) 1 $ 190,202,485 $ —

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)		9 Months Ended
	Feb. 13, 2024	Sep. 30, 2024	Sep. 30, 2023
Description of Organization and Business Operations [Line Items]
Share price per share (in Dollars per share)	$ 10
Aggregate private placement		$ 5,090,000
Transaction costs		8,180,834
Cash underwriting fee		1,840,000
Deferred underwriting fees		5,520,000
Other offering costs		$ 820,834
Percentage of fair market value		80%
Percentage of own acquire of the equity interests		100%
Transaction owns to acquires		100%
Net proceeds from sale of units	$ 184,000,000
Underwriting discounts	1,840,000
Payment of fees and expenses	3,250,000
Deposit account	$ 100,000,000,000
Minimum maturity term	185 days
Aggregate deposit in the trust account of business days	2 days
Anticipated public share (in Dollars per share)		$ 10
Percentage of restricted redeeming shares		20%
Percentage of redeem public shares		100%
Promptly business days		10 days
Redeem public shares, percentage		100%
Interest to pay dissolution expenses		$ 100,000
Price per share (in Dollars per share)		$ (10)
Trust account share price (in Dollars per share)		10
Reduction price (in Dollars per share)		$ 10
Taxes payable to interest to pay dissolutions expenses		$ 100,000
Business combination [Member]
Description of Organization and Business Operations [Line Items]
Issued and outstanding voting securities		50%
Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Line Items]
Gross proceeds		$ 184,000,000
Initial Public Offering [Member]
Description of Organization and Business Operations [Line Items]
Number of units issued in transaction (in Shares)		18,400,000
Share price per share (in Dollars per share)	$ 10	$ 10
Initial Public Offering [Member] | Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Line Items]
Number of units issued in transaction (in Shares)	18,400,000
Over-Allotment Option [Member]
Description of Organization and Business Operations [Line Items]
Number of units issued in transaction (in Shares)	2,400,000	2,400,000
Gross proceeds	$ 184,000,000
Private Placement Shares [Member]
Description of Organization and Business Operations [Line Items]
Aggregate private placement		$ 5,090,000
Private Placement Shares [Member] | Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Line Items]
Number of units issued in transaction (in Shares)		509,000
Share price per share (in Dollars per share)		$ 10

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Summary of Significant Accounting Policies [Line Items]
Cash	$ 1,785,636		$ 0
Tax provision	0
Federal depository insurance coverage	$ 250,000
Class B Ordinary Shares [Member]
Summary of Significant Accounting Policies [Line Items]
Antidilutive shares (in Shares)		600,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of Class A Ordinary Shares Subject to Redemption Reflected - Class A Ordinary Shares [Member] - USD ($)	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Schedule of Class A Ordinary Shares Subject to Redemption Reflected [Line Items]
Gross proceeds	$ 184,000,000
Less:
Class A ordinary shares issuance costs	(8,158,738)
Plus:
Accretion of carrying value to redemption value	14,362,142
Class A ordinary shares subject to possible redemption, September 30, 2024	$ 190,203,404

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income Per Ordinary Share - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Class A [Member]
Numerator:
Allocation of net income		$ 1,876,790		$ 4,398,352
Denominator:
Basic weighted average shares outstanding	[1]	18,909,000		15,872,518
Basic net income per share		$ 0.1		$ 0.28
Numerator:
Allocation of net income		$ 1,876,790		$ 4,377,652
Denominator:
Diluted weighted average shares outstanding	[1]	18,909,000		15,872,518
Diluted net income per share		$ 0.1		$ 0.28
Class B [Member]
Numerator:
Allocation of net income		$ 456,568		$ 1,247,984
Denominator:
Basic weighted average shares outstanding	[1],[2],[3]	4,600,000	4,000,000	4,503,650	4,000,000
Basic net income per share		$ 0.1	$ 0	$ 0.28	$ 0
Numerator:
Allocation of net income		$ 456,568		$ 1,268,684
Denominator:
Diluted weighted average shares outstanding	[1],[2],[3]	4,600,000	4,000,000	4,600,000	4,000,000
Diluted net income per share		$ 0.1	$ 0	$ 0.28	$ 0
[1] At September 30, 2023, excludes an aggregate of 600,000 Class B ordinary shares that are subject to forfeiture. As of September 30, 2023, excludes an aggregate of up to 600,000 Class B ordinary shares that are subject to forfeiture depending on the extent to which the underwriter’s over-allotment option is exercised. On February 13, 2024, simultaneously with the closing of the Initial Public Offering, the underwriter fully exercised its over-allotment option, and accordingly, the 600,000 Founder Shares are no longer subject to forfeiture (Note 5). On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor.

Public Offering (Details)

Public Offering (Details) - $ / shares		9 Months Ended
	Feb. 13, 2024	Sep. 30, 2024
Initial Public Offering [Member]
Public Offering [Line Items]
Amount of public shares		18,400,000
Share purchase price (in Dollars per share)	$ 10	$ 10
Over-Allotment Option [Member]
Public Offering [Line Items]
Amount of public shares	2,400,000	2,400,000

Private Placement (Details)

Private Placement (Details) - Private Placement [Member] - Sponsor [Member]	9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares shares
Private Placements [Line Items]
Purchased an aggregate shares | shares	509,000
Share price per share | $ / shares	$ 10
Aggregate purchase price | $	$ 5,090,000

Related Party Transactions (Det

Related Party Transactions (Details)						3 Months Ended	9 Months Ended
	Feb. 13, 2024 $ / shares shares	Feb. 08, 2024 USD ($) shares	Feb. 01, 2024 shares	Nov. 29, 2023 USD ($) $ / shares shares	Jun. 19, 2021 USD ($) shares	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($)
Related Party Transactions [Line Items]
After the completion period of business combination							1 year
Trading days							30 days
Fair value price per share (in Dollars per share) | $ / shares	$ 10
Administrative service expense (in Dollars) | $		$ 6,458
Aggregate principal amount (in Dollars) | $					$ 300,000
Promissory note (in Dollars) | $						$ 0	$ 0	$ 70,095
Working capital loans (in Dollars) | $							1,500,000
Sponsor [Member]
Related Party Transactions [Line Items]
Incurred fees (in Dollars) | $						$ 19,374	$ 48,435
Founder Shares [Member]
Related Party Transactions [Line Items]
Offering and formation costs (in Dollars) | $					$ 25,000
Exchanged shares				90,000
Subject to forfeiture		600,000
Number of founder shares				30,000
Number of sponsor holding shares		30,000
Number of independent directors		2
Number of advisor		1
Additional public shares	2,400,000
Share price (in Dollars per share) | $ / shares	$ 10
Trading days							20 days
Threshold period after the business combination commencing							150 days
Fair value of founder shares (in Dollars) | $				$ 309,600
Fair value price per share (in Dollars per share) | $ / shares				$ 3.44
Class B Ordinary Shares [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Exchanged shares					2,875,000
Capitalization shares			1,437,500
Number of sponsor holding shares		4,510,000	4,222,500
Class B Ordinary Shares [Member] | Sponsor [Member]
Related Party Transactions [Line Items]
Capitalization shares		287,500
Class A Ordinary Shares [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Closing price (in Dollars per share) | $ / shares							$ 12
Over-Allotment Option [Member]
Related Party Transactions [Line Items]
Exchanged shares	2,400,000						2,400,000
Over-Allotment Option [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Subject to forfeiture					562,500
Initial Public Offering [Member]
Related Party Transactions [Line Items]
Exchanged shares							18,400,000
Fair value price per share (in Dollars per share) | $ / shares	$ 10					$ 10	$ 10
Initial Public Offering [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Percentage of issued and outstanding shares after the initial public offering					20%
Initial Public Offering [Member] | Class A Ordinary Shares [Member]
Related Party Transactions [Line Items]
Exchanged shares	18,400,000
Private Placement [Member]
Related Party Transactions [Line Items]
Post-business combination price per share (in Dollars per share) | $ / shares							10
Private Placement [Member] | Sponsor [Member]
Related Party Transactions [Line Items]
Fair value price per share (in Dollars per share) | $ / shares						10	$ 10
Private Placement [Member] | Class A Ordinary Shares [Member]
Related Party Transactions [Line Items]
Exchanged shares							509,000
Fair value price per share (in Dollars per share) | $ / shares						$ 10	$ 10

Commitments (Details)

Commitments (Details) - USD ($)		9 Months Ended
	Feb. 13, 2024	Sep. 30, 2024
Commitments [Line Items]
Underwriters option period from the date of initial public offering		45 days
Public shares price per share	$ 10
Cash underwriting discount public share		$ 0.1
Underwriting deferred fee, per share		$ 0.3
Deferred underwriting fees (in Dollars)		$ 5,520,000
Over-Allotment Option [Member]
Commitments [Line Items]
Additional share purchased (in Shares)		2,400,000
Initial Public Offering [Member]
Commitments [Line Items]
Additional share purchased (in Shares)	2,400,000
Public shares price per share	$ 10	$ 10
Cash underwriting discount (in Dollars)		$ 1,840,000

Shareholders_ Deficit (Details)

Shareholders’ Deficit (Details)		9 Months Ended
		Sep. 30, 2024 $ / shares shares	Dec. 31, 2023 $ / shares shares
Shareholders’ Deficit [Line Items]
Preferred stock, shares authorized		5,000,000	5,000,000
Preferred stock, par value (in Dollars per share) | $ / shares		$ 0.0001	$ 0.0001
Preference shares issued
preference shares outstanding
Class A Ordinary Shares [Member]
Shareholders’ Deficit [Line Items]
Ordinary shares, shares authorized		500,000,000	500,000,000
Ordinary shares, par value (in Dollars per share) | $ / shares		$ 0.0001	$ 0.0001
Ordinary shares, number of votes per share		1
Ordinary shares, shares issued		509,000	0
Ordinary shares, shares outstanding		509,000	0
Ordinary share subject to possible redemption		18,400,000	18,400,000
Converted basis, percentage		20%
Class B Ordinary Shares [Member]
Shareholders’ Deficit [Line Items]
Ordinary shares, shares authorized	[1]	50,000,000	50,000,000
Ordinary shares, par value (in Dollars per share) | $ / shares	[1]	$ 0.0001	$ 0.0001
Ordinary shares, number of votes per share		1
Ordinary shares, shares issued	[1]	4,600,000	4,600,000
Ordinary shares, shares outstanding	[1]	4,600,000	4,600,000
[1] On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor.

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Fair Value Measurements [Line Items]
Assets held in trust account	$ 919
Cash	1,785,636	$ 0
US Treasury Securities [Member]
Fair Value Measurements [Line Items]
Cash	$ 190,202,485

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Marketable securities held in Trust Account held [Member] | Level 1 [Member]
Assets:
Marketable securities held in Trust Account held (Matures on August 15, 2024)	$ 190,202,485